Prostate Cancer Clinical Trial
Official title:
Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men
Objectives:
The primary objective of this project is to develop and evaluate a Spanish-language slide set
for administration in group settings, adapted from the content of the current guidelines and
existing, self-administered ACS early detection decision aid.
A guide for educators will accompany the slide set so that materials may be distributed on a
broad scale at the completion of the project. It is expected that these products will be made
available to community-based educators and screening programs to be used in support of an IDM
process for early detection of prostate cancer with Spanish-speaking men.
Specific Aims:
To conduct an extensive review of the literature and other resources to identify themes
related to early detection, concerns and beliefs about prostate cancer in Hispanic men.
Findings will be used to adapt the slideset.
To cognitive test the Spanish-language decision aid slide set with Hispanic men To conduct
focus groups to evaluate the acceptability of the adapted slide set with Spanish-speaking
Hispanic men who are candidates for prostate cancer screening. Participants will be tested
for their knowledge of prostate cancer and acceptability of materials (e.g. length, clarity,
amount and balance of information provided).
Cognitive Testing Interviews:
If you agree to take part in this study, you will complete a questionnaire about your
demographics (age, race, country of origin), education and family history of prostate cancer.
This questionnaire should take about 5 minutes to complete.
Then you will take part in a one on one interview with a bilingual member of the study staff.
You will be shown draft versions of a slide show about prostate cancer screening. You will
then be asked to describe the information in the slides in your own words. You will also be
asked about how easy or hard the information is to understand. The interview should last
about 1 hour.
Length of Study:
Answering the questionnaire and participating in the interview will take about 1 to 1½ hours
of your time. Your participation in this study will be over when the interview is complete.
Evaluation Focus Groups:
If you agree to take part in this study, you will complete 2 questionnaires about your
demographics (age, race, country of origin), education, family history of prostate cancer,
and knowledge of prostate cancer and its screening. These questionnaires should take about 10
minutes to complete. After the questionnaires, you will take part in a focus group with other
men and members of the study.
In the focus group, a bilingual study staff member will lead the discussion by showing the
group slides about prostate cancer screening. A doctor or healthcare professional designee
will be available to answer questions about prostate cancer screening.
After viewing the slides, you will complete another questionnaire about what you know about
prostate cancer. It will also ask what you thought about the information in the slides.
Length of Study:
Answering the questionnaires and participating in the focus group will take about 1 to 1½
hours of your time. Your participation in this study will be over when the focus group
session is complete.
This is an investigational study.
Up to 60 participants will take part in this multicenter study. Up to 10 will be enrolled at
MD Anderson.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Active, not recruiting |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |